Skip to content
The BCI Briefing

Patent familyBCI, high confidence

Combination therapy including peripheral nerve field stimulation

Filed by Medtronic, first in 2005.

Granted · EP, USView in Espacenet
Earliest priority
9 Jun 2005 · United States
Status
A grant was published in European Patent Office, United States, first on 7 Sep 2010
Published in
International (PCT) · United States · European Patent Office · Austria · Germany
Registered as
MEDTRONIC, INC.
Inventors
Rooney, Ethan A. · Wahlstrand, Carl D. · King, Gary W. · Cross, JR. Thomas E. · Heruth, Kenneth T. · Wacnik, Paul W. · and 1 more
Family
DOCDB 37459399 · 55 publications

What it concerns

Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.

The abstract as published by the patent office, from US2007021801A1. It describes the invention; it is not a statement of what is protected.

Protection themes

  • Interface and electrodes

    Electrodes and arrays · Peripheral interfaces

  • Packaging

    Packaging and hermeticity

  • Telemetry

    Wireless telemetry

  • Stimulation

    Stimulation

What the filing appears to be about, read by published rules from its title, abstract and classification codes (A61M2205/054, A61M5/14, A61M5/142, A61N1/0531, A61N1/0534). The claims define what a patent protects, and they are not read here.

Why it matters

Interface and electrodes
Everything downstream works with what the contacts pick up. Their number, size and distance from the neurons set the ceiling on the signal. The problem behind it: more contacts, closer to neurons, that still record after years in tissue that reacts to them.
Packaging
Body fluid destroys unprotected electronics. An implant meant to last has to stay sealed for years while passing every channel through its wall. The problem behind it: a seal that lasts as long as the patient needs it, at a size that leaves room for the channels.
Telemetry
Thousands of channels produce more data than a low-power radio can carry raw, so what is sent, and how, decides what the system can use. The problem behind it: high data rates at low power through tissue, reliably and securely.

Why the layer matters to the field, not a judgement of this filing. A patent family shows that protection was sought. It does not show that the technology was built, is used in a product, or works in people. The whole stack

The family

One invention, published 55 times in 5 offices. Each publication opens in Espacenet.

Timeline

  1. 9 Jun 2005First filingEarliest priority, at United States. The family is counted in this year.
  2. 14 Mar 2006ApplicationFiled at United States.
  3. 24 Apr 2006Owner recordedUnited States, on US2007021802A1: assignment; owner named: MEDTRONIC, INC., MINNESOTA.
  4. 9 Jun 2006ApplicationsFiled at International (PCT), United States, European Patent Office, Austria, Germany.
  5. 14 Dec 2006First publicationWO2006133443A2, International (PCT).
  6. 6 Aug 2008Office recordInternational (PCT), on WO2006135751A2: ep: pct application non-entry in european phase.
  7. 27 Aug 2010ApplicationFiled at United States.
  8. 15 Jul 2011Office recordAustria, on ATE496652T1: ceased as to paragraph 5 lit. 3 law introducing patent treaties.
  9. 17 Dec 2013ApplicationFiled at United States.
  10. 30 Dec 2013ApplicationFiled at United States.
  11. 24 Apr 2015ApplicationFiled at United States.
  12. 26 Aug 2015Owner recordedEuropean Patent Office, on EP1904173A2: party data changed (applicant data changed or rights of an application transferred); owner named: MEDTRONIC INC..
  13. 28 Mar 2016ApplicationFiled at United States.
  14. 18 May 2016Owner recordedEuropean Patent Office, on EP1904173A2: party data changed (patent owner data changed or rights of a patent transferred); owner named: MEDTRONIC, INC..
  15. 8 Jun 2016Grant publishedEP1904173B8, European Patent Office.
  16. 8 Apr 2019ApplicationFiled at United States.
  17. 26 Oct 2021Grant publishedUS11154709B2, United States.
  18. 31 May 2023Office recordEuropean Patent Office, on EP1904173A2: lapsed in a contracting state [announced via postgrant information from national office to epo] (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR).
  19. 13 Jan 2026Office recordUnited States, on US2007073353A1: lapsed due to failure to pay maintenance fee.

Dates as the offices published them. Office records are in the offices' own words and are a selection: refusals, lapses and withdrawals, and records that name an owner. Each concerns one member of the family, not the family as a whole, and another member in the same office may stand. Whether a patent is in force today is not assessed.

Sources

  • Bibliographic data, family members and office records: European Patent Office, Open Patent Services (the DOCDB and INPADOC databases), read 7 Oct 2026.
  • The record itself, with its claims and description: US2007021801A1 in Espacenet
  • Counted as a BCI patent family: classified A61N1/0531 (brain cortex electrodes); filed by MEDTRONIC, INC., an organisation already in the graph; describes neural hardware or methods without naming the field. How families are found and judged